A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Bengaluru: New findings presented at ObesityWeek® 2025 have unveiled promising results for an investigational daily pill ...

Trials have shown that semaglutide can reduce major cardiovascular events, but the extent of tirzepatide’s heart protection ...

The ZENITH trial showed sotatercept significantly reduced death, transplant, or hospitalization risk in advanced PAH, leading ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Oral semaglutide for weight loss could be a game-changer for obesity care in India: Our Bureau, Mumbai Thursday, December 11, 2025, 15:30 Hrs [IST] New findings presented at Obesi ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to ...

Inflammation likely plays a key role in T2D outcomes, and various anti-inflammatory treatments may improve both T2D and its ...

Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division recommended Willow ...